Deflux

Entity type image
Type: Product
Name: Deflux
First reported May 17 2013 - Updated May 17 2013 - 1 reports

deflux distributor 1.0

The Deflux App for Business Managers and Distribution Professionals. This application features several categories. Each category contains Deflux product content, such as brochures and technical sheets.THe content in each section is controlled by a Deflux ... [Published Addict3d.org - May 17 2013]
Entities: Deflux

Quotes

Adam Derbyshire, Executive Vice President and Chief Financial Officer, noted, "XIFAXAN 550 mg continued to perform well during the first quarter of 2013. During the quarter our XIFAXAN 550 mg prescription business demonstrated impressive growth of 26 percent compared to the first quarter of 2012. Apriso also demonstrated strong prescription year-over-year growth of 11 percent for the first quarter of 2013 compared to the first quarter of 2012. RELISTOR prescriptions increased 52 percent year-over-year for the first quarter of 2013 compared to the first quarter of 2012."

More Content

All (6) | News (3) | Reports (1) | Blogs (0) | Audio/Video (0) | Fact Sheets (2) | Press Releases (0)
sort by: Date | Relevance
Salix Pharmaceuticals Updates on 1Q2013 Results... [Published Equities.com - 8 hours ago]
deflux distributor 1.0 [Published Addict3d.org - May 17 2013]
Salix Beats on Earnings Zacks [Published Yahoo! Finance - May 14 2013]
Salix Pharmaceuticals Management Discusses Q1 2... [Published Seeking Alpha - May 10 2013]
Fact Sheet for Q-Med AB [Published Able2Act - Jul 16 2008]
Fact Sheet for Q-Med [Published Able2Act - Feb 12 2008]
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2013 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.